ORIC
ORIC
NASDAQ · Biotechnology

Oric Pharmaceuticals Inc

$9.12
+0.19 (+2.13%)
As of Jun 23, 2:21 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +473.0% upside
Low Target $31.55
Average Target $52.26
High Target $71.26
Current Price $9.12
Current
$9.12
Target
$52.26
$31.55 $52.26 avg $71.26
Scenario Analysis
Bear Case
$31.55
245.9%
Low target
Base Case
$52.26
+473.0%
Avg target
Bull Case
$71.26
+681.4%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$14.93
-38.9% from high
52-Week Low
$7.23
+26.1% from low
Target vs 52W High
$52.26
+250.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%